• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pembrolizumab in MSI-H-dMMR Advanced Colorectal Cancer - A New Standard of Care.

作者信息

Grothey Axel

机构信息

From GI Cancer Research, West Cancer Center and Research Institute, Germantown, TN.

出版信息

N Engl J Med. 2020 Dec 3;383(23):2283-2285. doi: 10.1056/NEJMe2031294.

DOI:10.1056/NEJMe2031294
PMID:33264550
Abstract
摘要

相似文献

1
Pembrolizumab in MSI-H-dMMR Advanced Colorectal Cancer - A New Standard of Care.帕博利珠单抗用于微卫星高度不稳定/d错配修复缺陷的晚期结直肠癌——一种新的治疗标准
N Engl J Med. 2020 Dec 3;383(23):2283-2285. doi: 10.1056/NEJMe2031294.
2
New first-line therapy for dMMR/MSI-H CRC.错配修复缺陷/微卫星高度不稳定结直肠癌的新型一线治疗方案
Nat Rev Clin Oncol. 2021 Feb;18(2):63. doi: 10.1038/s41571-020-00464-y.
3
Pembrolizumab: a new standard of care in metastatic colorectal cancer.帕博利珠单抗：转移性结直肠癌的新治疗标准
Immunotherapy. 2021 Oct;13(15):1245-1247. doi: 10.2217/imt-2021-0051. Epub 2021 Sep 20.
4
[Pembrolizumab as first-line therapy in microsatellite instability metastatic colorectal cancers].帕博利珠单抗作为微卫星不稳定转移性结直肠癌的一线治疗方案
Bull Cancer. 2021 Mar;108(3):229-231. doi: 10.1016/j.bulcan.2021.01.004. Epub 2021 Feb 23.
5
Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.程序性死亡配体-1检测及免疫疗法在微卫星不稳定的结直肠癌中是否有作用？第一部分——结直肠癌：微卫星不稳定、检测及临床意义
Arch Pathol Lab Med. 2018 Jan;142(1):17-25. doi: 10.5858/arpa.2017-0040-RA. Epub 2017 Nov 16.
6
[New drug arrival : Pembrolizumab as second-line treatment in MSI-H/dMMR endometrial, colorectal, gastric, intestinal and biliary cancers].新药来袭：帕博利珠单抗作为微卫星高度不稳定/错配修复缺陷型子宫内膜癌、结直肠癌、胃癌、小肠癌和胆管癌的二线治疗药物
Bull Cancer. 2023 Jan;110(1):11-13. doi: 10.1016/j.bulcan.2022.10.003. Epub 2022 Nov 7.
7
Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal Cancer.联合微卫星不稳定性和在选定四核苷酸重复序列处升高的微卫星改变（EMAST）可能是结直肠癌更有前途的免疫生物标志物。
Oncologist. 2019 Dec;24(12):1534-1542. doi: 10.1634/theoncologist.2019-0171. Epub 2019 Jul 10.
8
Clinical implications of microsatellite instability in T1 colorectal cancer.T1期结直肠癌中微卫星不稳定性的临床意义
Yonsei Med J. 2015 Jan;56(1):175-81. doi: 10.3349/ymj.2015.56.1.175.
9
FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors.美国食品药品监督管理局批准摘要：帕博利珠单抗用于治疗微卫星高度不稳定实体瘤。
Clin Cancer Res. 2019 Jul 1;25(13):3753-3758. doi: 10.1158/1078-0432.CCR-18-4070. Epub 2019 Feb 20.
10
Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) and Microsatellite Instability in Patients with Colorectal Cancer and Its Clinical Features.结直肠癌患者中选定四核苷酸重复序列的微卫星改变升高（EMAST）及微卫星不稳定性及其临床特征
Curr Mol Med. 2016;16(9):829-839. doi: 10.2174/1566524016666161124103020.

引用本文的文献

1
Prognosis and influencing factors of patients with different lymph node statuses after pathological complete response to neoadjuvant chemoradiotherapy in rectal cancer.直肠癌新辅助放化疗后病理完全缓解的不同淋巴结状态患者的预后及影响因素
Oncol Lett. 2025 May 22;30(1):359. doi: 10.3892/ol.2025.15105. eCollection 2025 Jul.
2
Effectiveness and Safety of Immune Checkpoint Inhibitors in Colorectal Cancer: A Systematic Review of Real-World Studies.免疫检查点抑制剂在结直肠癌中的有效性和安全性：真实世界研究的系统评价
Curr Oncol Rep. 2025 May 13. doi: 10.1007/s11912-025-01676-0.
3
What Is Next for Refractory Colorectal Cancer CRC? Looking Beyond SUNLIGHT, FRESCO2, RECURSE and CORRECT.
难治性结直肠癌（CRC）的下一步是什么？超越SUNLIGHT、FRESCO2、RECURSE和CORRECT试验进行展望。
Int J Mol Sci. 2025 Mar 11;26(6):2522. doi: 10.3390/ijms26062522.
4
The diagnostic value of histogram analysis of DWI and DKI for the mismatch repair status of rectal adenocarcinoma.扩散加权成像（DWI）和扩散峰度成像（DKI）直方图分析对直肠腺癌错配修复状态的诊断价值。
Heliyon. 2024 Sep 5;10(18):e37526. doi: 10.1016/j.heliyon.2024.e37526. eCollection 2024 Sep 30.
5
Oncological characteristics, treatments and prognostic outcomes in MMR-deficient colorectal cancer.错配修复缺陷型结直肠癌的肿瘤学特征、治疗方法及预后结果
Biomark Res. 2024 Aug 26;12(1):89. doi: 10.1186/s40364-024-00640-7.
6
Efficacy comparison of fruquintinib, regorafenib monotherapy or plus programmed death-1 inhibitors for microsatellite stable metastatic colorectal cancer.呋喹替尼、瑞戈非尼单药治疗或联合程序性死亡-1抑制剂用于微卫星稳定型转移性结直肠癌的疗效比较
World J Gastrointest Oncol. 2024 Jun 15;16(6):2449-2462. doi: 10.4251/wjgo.v16.i6.2449.
7
Biomarkers in Cancer Detection, Diagnosis, and Prognosis.癌症检测、诊断和预后中的生物标志物。
Sensors (Basel). 2023 Dec 20;24(1):37. doi: 10.3390/s24010037.
8
ATM Inhibition-Induced ISG15/IFI27/OASL Is Correlated with Immunotherapy Response and Inflamed Immunophenotype.ATM 抑制诱导的 ISG15/IFI27/OASL 与免疫治疗反应和炎症免疫表型相关。
Cells. 2023 Apr 30;12(9):1288. doi: 10.3390/cells12091288.
9
Young-onset colorectal cancer.青年结直肠癌。
Nat Rev Dis Primers. 2023 Apr 27;9(1):21. doi: 10.1038/s41572-023-00432-7.
10
Neoadjuvant immune checkpoint inhibition in the management of glioblastoma: Exploring a new frontier.新辅助免疫检查点抑制在胶质母细胞瘤治疗中的应用：探索新前沿。
Front Immunol. 2023 Feb 17;14:1057567. doi: 10.3389/fimmu.2023.1057567. eCollection 2023.